Wolff Wiese Magana’s Cidara Therapeutics CDTX Stock Holding History

Wolff Wiese Magana’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-58	Closed	-$12.8K	–	992
2025 Q4	$12.8K	Buy	+58	New	+$9.37K	0.01%	394

Wolff Wiese Magana's CDTX Position: Q1 2026 in Review

Wolff Wiese Magana sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 58 shares — an estimated $12.8K sold.

Wolff Wiese Magana first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $12.8K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Wolff Wiese Magana reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Wolff Wiese Magana sold 58 Cidara Therapeutics shares in Q1 2026, an estimated $12.8K.
Wolff Wiese Magana first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Wolff Wiese Magana's Cidara Therapeutics position peaked at $12.8K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Wolff Wiese Magana's 13F filing for Q1 2026, filed 13 Apr 2026.